Please login to the form below
Pfizer gets FDA panel recommendation for biosimilar EPO
Product could be the first direct competitor to Epogen and Procrit in the US
Biogen spin-out makes first acquisition
Bioverativ attains rare disease group True North
Germany’s pharma market set for stable growth
Annual growth of 4.9% expected over next four years
Recordati acquires AstraZeneca blood pressure brands
Italian pharma firm obtains Seloken and Logimax
MSD probed by UK for blocking Remicade biosimilars
Pharma giant’s discount scheme for infliximab labelled ‘anti-competitive’
Keytruda is first FDA-approved drug for molecular indication
Indicates a significant development in the shift towards personalised medicine
Otsuka refiles 'digital' medicine for mental illness
Soluble sensor tracks drug ingestion and shares information with HCPs
Merck says Afferent’s chronic cough drug clears mid-stage trial
MK-7264 reduces coughs per hour by 37%
Sanofi/Regeneron's Sarilumab cleared by FDA on second attempt
IL-6 inhibitor to treat adult RA patients
The new science of content marketing
The role of big data and artificial intelligence in marketing and advertising
-
The Communiqué Awards at 20: Sarah MatthewThe president of Golin's global health practice on her long-standing association with the awards
-
Healthcare transformation and innovationThe healthcare and technology revolution
-
Porterhouse Medical expands its offerings
Med-comms agency opens new office in Reading
-
Payback time nears as Sanofi gets CHMP backing for biosimilar HumalogPanel recommends insulin Lispro Sanofi to treat diabetes
-
Novartis' Zykadia prepped to take on Xalkori in EuropeThe Swiss pharma giant’s drug will treat ALK-positive NSCLC patients
-
Research Partnership expands across AmericaFirm opens new offices in San Francisco and New York
-
Novartis' Swiss head of operations reveals job cutsLeuenberger suggests cuts are needed to maintain competiveness
-
Merck takes on Roche with first-line bladder OK for KeytrudaFDA awards accelerated approval for mUC patients
-
Merck and Pfizer claim second FDA nod for cancer drug BavencioAnalysts predict it will bring in sales of around $600m by 2020
Latest appointments
-
VCLS appoints Carole Jones to senior market access roleShe joins from Envision Pharma Group
-
Consilium appoints Philippa Gardner and Suki VirjiUK comms agency adds to its senior international healthcare team
-
Clark Health Communications expands teamAppoints new account director Kayleigh Moore and promotes team members
-
Astellas appoints new senior VP Shontelle Dodson also takes on head of Medical Affairs Americas role
-
GW Pharmaceuticals strengthens research and development teamAppoints Dr Volker Knappertz and Professor Ben Whalley
Featured jobs
- Account Director, Healthcare Communications
-
£50, 000 - £60, 000
- Account Director, Digital Healthcare Communications Agency
-
£45, 000 – £55, 000 benefits
- Senior Account Manager/ Account Director, Medical Communications...
-
Excellent package
- Account Director, Medical Communications
-
£60, 000 – £65, 000 benefits
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
-
Director, Scientific Services
-
£80 – 90, 000 benefits
- Editorial Teal Leader, Medical Communications, London
-
Excellent package
- Senior Medical Writer, Medical Communications, London
-
Excellent package
- Pharmaceutical Associate Director, PR
-
£85, 000 - £100, 000 generous package
- Programme Director - Healthcare PR - London
-
Salary TBC
- FREELANCE ACCOUNT DIRECTOR - MED ED OR HEALTHCARE PR - LONDON - ...
-
SUPERB DAY RATE AVAILABLE
Subscribe to our email news alerts
- Novartis' Swiss head of operations reveals job cuts
- Otsuka refiles 'digital' medicine for mental illness
- Payback time nears as Sanofi gets CHMP backing for biosimilar Humalog
- Sanofi/Regeneron's Sarilumab cleared by FDA on second attempt
- Keytruda is first FDA-approved drug for molecular indication
- MSD probed by UK for blocking Remicade biosimilars
- Cactus Medical Communication Services
- Digital storytelling means building the story around data
- Pfizer gets FDA panel recommendation for biosimilar EPO
- Biogen spin-out makes first acquisition
- Pharma and free medicines: a different perspective
- TVF Communications shortlisted for the second year in a row for Writing Excellence award at Communique 2017
PMHub
CACTUS
Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...
Latest intelligence
- Digital storytelling means building the story around data
- The value of digital storytelling in pharma lies in its ability to convert facts and figures into compelling content for patients and HCPs....
- Pharma and free medicines: a different perspective
- Pfizer have recently announced that they will provide the breast cancer drug, palbociclib, free of charge to patients....
- The false economy of following the leader
- How can companies in the sector shake things up?...
Quick links
Infographics
